Qube Research & Technologies (QRT)
CLBT icon

Qube Research & Technologies (QRT)’s Cellebrite CLBT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Sell
141,084
-502,527
-78% -$6.64M ﹤0.01% 2110
2026
Q1 		$8.87M Buy
643,611
+103,393
+19% +$1.56M 0.01% 1351
2025
Q4 		$9.74M Sell
540,218
-254,279
-32% -$4.57M 0.01% 1366
2025
Q3 		$14.7M Sell
794,497
-706,008
-47% -$11.1M 0.02% 1078
2025
Q2 		$24M Buy
1,500,505
+725,679
+94% +$12.9M 0.02% 791
2025
Q1 		$15.1M Buy
774,826
+179,705
+30% +$3.78M 0.02% 885
2024
Q4 		$13.1M Buy
595,121
+310,258
+109% +$5.97M 0.02% 939
2024
Q3 		$4.8M Buy
+284,863
New +$4.23M 0.01% 1411
2024
Q2 		– Sell
-26,233
Closed -$291K – 3902
2024
Q1 		$291K Buy
26,233
+12,249
+88% +$125K ﹤0.01% 2836
2023
Q4 		$121K Buy
+13,984
New +$109K ﹤0.01% 3032

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLBT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Cellebrite (CLBT) stake by 78% in Q2 2026, selling an estimated $6.64M and leaving 141,084 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Qube Research & Technologies (QRT) first reported a position in CLBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $24M in Q2 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 141,084 shares of Cellebrite worth $2.06M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 502,527 Cellebrite shares in Q2 2026, an estimated $6.64M.
  • Cellebrite made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2110 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cellebrite in Q4 2023 and has held it in 10 quarters since.
  • Qube Research & Technologies (QRT)'s Cellebrite position peaked at $24M in Q2 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.